We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
401
Fifth Third Bancorp
FITB
$51.2B
$1.8M 0.05%
66,907
-43,855
-40% -$1.05M
ETN icon
402
Eaton
ETN
$161B
$1.8M 0.05%
26,872
-5,286
-16% -$347K
MHK icon
403
Mohawk Industries
MHK
$7.5B
$1.8M 0.05%
9,022
-148
-2% -$29.1K
WPXP
404
DELISTED
WPX Energy, Inc.
WPXP
$1.79M 0.05%
27,326
-2,379
-8% -$145K
ADM icon
405
Archer Daniels Midland
ADM
$38.2B
$1.79M 0.05%
39,250
+248
+0.6% +$11K
HRB icon
406
H&R Block
HRB
$5.58B
$1.78M 0.05%
77,596
-17,979
-19% -$411K
FR icon
407
First Industrial Realty Trust
FR
$8.73B
$1.78M 0.05%
63,550
-2,200
-3% -$58.6K
DOC icon
408
Healthpeak Properties
DOC
$15.1B
$1.77M 0.05%
59,460
-12,835
-18% -$391K
DST
409
DELISTED
DST Systems Inc.
DST
$1.77M 0.05%
33,000
MCHP icon
410
Microchip Technology
MCHP
$40.3B
$1.77M 0.05%
55,102
+8,506
+18% +$268K
VO icon
411
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$1.77M 0.05%
53,688
+1,344
+3% +$43.5K
DOV icon
412
Dover
DOV
$27.6B
$1.76M 0.05%
29,062
-1,189
-4% -$68.7K
TRMB icon
413
Trimble
TRMB
$13.2B
$1.75M 0.05%
+58,192
New +$1.67M
WST icon
414
West Pharmaceutical
WST
$24B
$1.75M 0.05%
20,689
VTI icon
415
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$1.75M 0.05%
15,158
-1,600
-10% -$180K
TLT icon
416
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$1.75M 0.05%
14,663
+9,988
+214% +$1.25M
EQR icon
417
Equity Residential
EQR
$24.9B
$1.75M 0.05%
27,132
-495
-2% -$30.4K
CEF icon
418
Sprott Physical Gold and Silver Trust
CEF
$7.4B
$1.74M 0.05%
153,923
+5,356
+4% +$67K
VXF icon
419
Vanguard Extended Market ETF
VXF
$30.3B
$1.69M 0.05%
17,650
+1,266
+8% +$117K
IGR
420
CBRE Global Real Estate Income Fund
IGR
$709M
$1.69M 0.05%
231,099
+2,267
+1% +$17K
VAR
421
DELISTED
Varian Medical Systems, Inc.
VAR
$1.68M 0.05%
21,384
-2
-0% -$162
CTSH icon
422
Cognizant
CTSH
$24.9B
$1.68M 0.05%
30,006
-4,105
-12% -$220K
VB icon
423
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$1.67M 0.05%
12,947
+753
+6% +$93.5K
BWA icon
424
BorgWarner
BWA
$13.1B
$1.66M 0.05%
47,839
+7,953
+20% +$256K
SCG
425
DELISTED
Scana
SCG
$1.66M 0.05%
22,597
-1,096
-5% -$78.2K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.